ACUTE LEUKEMIAS
Clinical trials for ACUTE LEUKEMIAS explained in plain language.
Never miss a new study
Get alerted when new ACUTE LEUKEMIAS trials appear
Sign up with your email to follow new studies for ACUTE LEUKEMIAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise for Hard-to-Treat leukemia
Disease control Recruiting nowThis study tests a new oral drug called bleximenib for people with acute leukemia that has come back or not responded to treatment. The drug targets specific genetic changes in the cancer cells. The trial has two phases: first to find the safest dose, then to see how well it work…
Matched conditions: ACUTE LEUKEMIAS
Phase: PHASE1, PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New stem cell transplant option for patients without a perfect donor match
Disease control Recruiting nowThis expanded access program offers a stem cell transplant using donor cells that have been specially processed to remove certain immune cells, reducing the risk of graft-versus-host disease. It is for patients with serious blood disorders, immune deficiencies, or metabolic disea…
Matched conditions: ACUTE LEUKEMIAS
Phase: EARLY_PHASE1 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Tiny trial tracks leukemia Drug's journey through the body
Knowledge-focused Recruiting nowThis early-stage study with 10 adults with acute leukemia looks at how the body absorbs, breaks down, and gets rid of the drug bleximenib. Participants take a radioactive version of the drug so researchers can track it in urine and stool. The goal is to understand the drug's path…
Matched conditions: ACUTE LEUKEMIAS
Phase: PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC